Letter to the editor: Does a "false-negative" MIBG scan predict a better outcome in neuroblastoma patients? [2]

Medical and Pediatric Oncology

Volumn 37, Issue 4, 2001, Pages 418-

  Garaventa, Alberto ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

CANCER SCINTISCANNING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; LETTER; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; CHILD; FEMALE; LABORATORY DIAGNOSIS; MALE; NOTE; PREDICTION AND FORECASTING; PRESCHOOL CHILD; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

3-IODOBENZYLGUANIDINE; CHILD; CHILD, PRESCHOOL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MALE; NEUROBLASTOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 18244418659     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1191     Document Type: Letter

References (2)

1. False-negative metaiodobenzylguanidine scintigraphy at diagnosis of neuroblastoma
2. Does a "false negative" MIBG scan predict a better outcome in neuroblastoma patients?